The global closed system transfer devices market is on a strong growth trajectory, with market sales expected to rise from USD 1,028.8 million in 2024 to USD 2,283.5 million by 2034. This expansion ...
Experts predict that in the next three to five years, China's AI-supported drug research will enter a phase of rapid development, with AI technologies taking on comprehensive research tasks such as ...
Stereotaxis targets growth with 2025 product milestones, MAGiC Sweep revenue, and EMAGIN 5F innovation, setting the stage for ...
In this week’s InnovationRx newsletter, tariffs could hit medical devices, a gene therapy company that helps blind kids see ...
10d
Medical Device Network on MSNPhilips pulls endovascular implant from market after FDA Class I recall tagPhilips has recommended that customers immediately stop using affected Tack endovascular systems and return unused product to ...
© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...
These claims are false. In China, drug crimes carry even harsher penalties than economic crimes, and counter-narcotics efforts are a highly decisive factor in evaluating local officials' career ...
India's contract drug manufacturers have gained from global companies' efforts to diversify their supply chain after the pandemic and a US bill that would prohibit federal contracts with certain ...
Industry expert Liu Xingliang highlights how this upgrade will enhance efficiency and user experience across various home devices. China’s top tech giants, including Huawei and Tencent ...
WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop ...
China’s joyful embrace of DeepSeek has gone one step deeper ... Many of these home goods are already smart devices that respond to voice-activated commands. But DeepSeek’s models will allow for far ...
Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company currently valued at $1.22 billion, announced today that China's Center for Drug Evaluation ... is a first-in-class phosphate absorption ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results